Citigroup
ZYME icon

Citigroup’s Zymeworks ZYME Stock Holding History

Citigroup’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Buy
131,441
+17,114
+15% +$435K ﹤0.01% 2474
2026
Q1 		$2.86M Buy
114,327
+3,120
+3% +$73.8K ﹤0.01% 2418
2025
Q4 		$2.93M Sell
111,207
-6,597
-6% -$144K ﹤0.01% 2404
2025
Q3 		$2.01M Sell
117,804
-38,194
-24% -$547K ﹤0.01% 2672
2025
Q2 		$1.96M Buy
155,998
+114,800
+279% +$1.37M ﹤0.01% 2667
2025
Q1 		$491K Sell
41,198
-41,938
-50% -$572K ﹤0.01% 3694
2024
Q4 		$1.22M Buy
83,136
+3,246
+4% +$45.4K ﹤0.01% 3209
2024
Q3 		$1M Buy
79,890
+25,179
+46% +$274K ﹤0.01% 3263
2024
Q2 		$466K Buy
54,711
+33,998
+164% +$303K ﹤0.01% 3440
2024
Q1 		$218K Sell
20,713
-5,256
-20% -$58.4K ﹤0.01% 3980
2023
Q4 		$270K Sell
25,969
-34,038
-57% -$271K ﹤0.01% 3788
2023
Q3 		$380K Sell
60,007
-26,012
-30% -$192K ﹤0.01% 3273
2023
Q2 		$743K Buy
86,019
+10,568
+14% +$94.6K ﹤0.01% 3061
2023
Q1 		$682K Buy
75,451
+49,593
+192% +$432K ﹤0.01% 2878
2022
Q4 		$203K Buy
25,858
+25,810
+53,771% +$181K ﹤0.01% 3714
2022
Q3 		$0 Sell
48
-565
-92% -$3.41K ﹤0.01% 6391
2022
Q2 		$3K Sell
613
-862
-58% -$5.21K ﹤0.01% 5809
2022
Q1 		$10K Buy
1,475
+665
+82% +$5.93K ﹤0.01% 5553
2021
Q4 		$13K Buy
810
+78
+11% +$1.63K ﹤0.01% 5516
2021
Q3 		$22K Sell
732
-1,172
-62% -$39K ﹤0.01% 5207
2021
Q2 		$66K Sell
1,904
-1,936
-50% -$61.4K ﹤0.01% 4682
2021
Q1 		$121K Sell
3,840
-1,026
-21% -$41.7K ﹤0.01% 4274
2020
Q4 		$230K Buy
4,866
+208
+4% +$9.66K ﹤0.01% 4880
2020
Q3 		$217K Sell
4,658
-5,538
-54% -$190K ﹤0.01% 4555
2020
Q2 		$367K Buy
10,196
+6,143
+152% +$226K ﹤0.01% 4538
2020
Q1 		$143K Buy
4,053
+2,318
+134% +$94.9K ﹤0.01% 5031
2019
Q4 		$79K Buy
+1,735
New +$63K ﹤0.01% 5963

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Citigroup's ZYME Position: Q2 2026 in Review

Citigroup increased its Zymeworks (ZYME) stake by 15% in Q2 2026, buying an estimated $435K and bringing the position to 131,441 shares worth $3.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2474.

Citigroup first reported a position in ZYME in Q4 2019 and has held it in 27 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Citigroup held 131,441 shares of Zymeworks worth $3.44M as of Q2 2026.
  • Citigroup bought 17,114 Zymeworks shares in Q2 2026, an estimated $435K.
  • Zymeworks made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2474 holding.
  • Citigroup first reported a position in Zymeworks in Q4 2019 and has held it in 27 quarters since.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.